Osborn Williams & Donohoe’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$5.19M Sell
57,575
-633
-1% -$67.3K 0.68% 46
2019
Q4
$6.6M Buy
58,208
+1,561
+3% +$171K 0.66% 48
2019
Q3
$6.15M Buy
56,647
+4,732
+9% +$494K 0.62% 47
2019
Q2
$5.06M Sell
51,915
-1,002
-2% -$91.5K 0.52% 56
2019
Q1
$4.64M Buy
52,917
+22,755
+75% +$2.04M 0.48% 60
2018
Q4
$2.74M Sell
30,162
-1,367
-4% -$128K 0.48% 60
2018
Q3
$3.1M Hold
31,529
0.48% 58
2018
Q2
$2.7M Sell
31,529
-280
-0.9% -$23.4K 0.46% 64
2018
Q1
$2.55M Buy
31,809
+795
+3% +$65.6K 0.44% 63
2017
Q4
$2.5M Sell
31,014
-143
-0.5% -$11.5K 0.43% 64
2017
Q3
$2.42M Sell
31,157
-1,050
-3% -$87.2K 0.44% 65
2017
Q2
$2.86M Buy
32,207
+850
+3% +$71.7K 0.52% 58
2017
Q1
$2.53M Buy
31,357
+3,231
+11% +$252K 0.46% 63
2016
Q4
$2M Buy
28,126
+1,743
+7% +$137K 0.38% 72
2016
Q3
$2.28M Sell
26,383
-866
-3% -$75.5K 0.44% 68
2016
Q2
$2.36M Sell
27,249
-175
-0.6% -$14.2K 0.46% 64
2016
Q1
$2.06M Buy
27,424
+1,058
+4% +$79.7K 0.41% 68
2015
Q4
$2.03M Sell
26,366
-576
-2% -$43.4K 0.42% 68
2015
Q3
$1.79M Sell
26,942
-170
-0.6% -$12.5K 0.39% 68
2015
Q2
$2.06M Sell
27,112
-2,450
-8% -$187K 0.41% 66
2015
Q1
$2.31M Buy
29,562
+5,868
+25% +$445K 0.45% 64
2014
Q4
$1.71M Buy
23,694
+6,716
+40% +$467K 0.34% 79
2014
Q3
$1.05M Buy
16,978
+2,117
+14% +$135K 0.22% 95
2014
Q2
$948K Sell
14,861
-174
-1% -$10.6K 0.2% 102
2014
Q1
$925K Sell
15,035
-1,199
-7% -$69.8K 0.2% 96
2013
Q4
$932K Sell
16,234
-298
-2% -$16.9K 0.21% 96
2013
Q3
$880K Sell
16,532
-149
-0.9% -$8.02K 0.21% 97
2013
Q2
$859K Buy
+16,681
New +$825K 0.22% 97

Other funds holding MDT

Osborn Williams & Donohoe's MDT Position: Q1 2020 in Review

Osborn Williams & Donohoe reduced its Medtronic (MDT) stake by 1.1% in Q1 2020, selling an estimated $67.3K and leaving 57,575 shares worth $5.19M. The position accounts for 0.68% of the portfolio, ranked #46.

Osborn Williams & Donohoe first reported a position in MDT in Q2 2013 and has held it in 28 quarters since. The position peaked at $6.6M in Q4 2019. 1,762 funds tracked by Wall St. Rank hold MDT as of Q1 2020.

  • Osborn Williams & Donohoe held 57,575 shares of Medtronic worth $5.19M as of Q1 2020.
  • Osborn Williams & Donohoe sold 633 Medtronic shares in Q1 2020, an estimated $67.3K.
  • Medtronic made up 0.68% of Osborn Williams & Donohoe's portfolio in Q1 2020, its #46 holding.
  • Osborn Williams & Donohoe first reported a position in Medtronic in Q2 2013 and has held it in 28 quarters since.
  • Osborn Williams & Donohoe's Medtronic position peaked at $6.6M in Q4 2019.
  • 1,762 funds tracked by Wall St. Rank held Medtronic as of Q1 2020.

Based on Osborn Williams & Donohoe's 13F filing for Q1 2020, filed 4 May 2020.